Corticotropin-releasing hormone is a potent stimulator of synthesis and secretion of preopiomelanocortin-derived peptides. Although CRH concentrations in the human peripheral circulation are normally low, they increase throughout pregnancy and fall rapidly after parturition. Maternal plasma CRH probably originates from the placenta. Human plasma contains a CRH-binding protein which inactivates CRH and which may prevent inappropriate pituitary-adrenal stimulation in pregnancy.[6]
Behan DP, De Souza EB, Lowry PJ, et al. (1996). "Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides". Frontiers in Neuroendocrinology. 16 (4): 362–82. doi:10.1006/frne.1995.1013. PMID8557170. S2CID1704154.
Vamvakopoulos NC, Sioutopoulou TO, Durkin SA, et al. (1995). "Mapping the human corticotropin releasing hormone binding protein gene (CRHBP) to the long arm of chromosome 5 (5q11.2-q13.3)". Genomics. 25 (1): 325–7. doi:10.1016/0888-7543(95)80151-B. PMID7774945.
Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID8125298.
Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID9373149.
Wetzka B, Sehringer B, Schäfer WR, et al. (2004). "Expression patterns of CRH, CRH receptors, and CRH binding protein in human gestational tissue at term". Exp. Clin. Endocrinol. Diabetes. 111 (3): 154–61. doi:10.1055/s-2003-39778. PMID12784189.
Claes S, Villafuerte S, Forsgren T, et al. (2003). "The corticotropin-releasing hormone binding protein is associated with major depression in a population from Northern Sweden". Biol. Psychiatry. 54 (9): 867–72. doi:10.1016/S0006-3223(03)00425-6. PMID14573312. S2CID21112652.